Revolution Medicines, Inc. — All Filings
764 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002203 | Mar 27, 2026 | — |
| 4 | — | 0001610717-26-000137 | Mar 26, 2026 | Mar 25, 2026 |
| 144 | — | 0002124509-26-000002 | Mar 26, 2026 | — |
| 3 | — | 0001610717-26-000136 | Mar 26, 2026 | Mar 20, 2026 |
| 3 | — | 0001610717-26-000135 | Mar 26, 2026 | Mar 20, 2026 |
| 4 | — | 0001610717-26-000132 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000131 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000130 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000129 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000128 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000127 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000126 | Mar 19, 2026 | Mar 17, 2026 |
| 144 | — | 0001950047-26-002833 | Mar 19, 2026 | — |
| 144 | — | 0001849181-26-000001 | Mar 13, 2026 | — |
| 144 | — | 0001872772-26-000002 | Mar 13, 2026 | — |
| 144 | — | 0001462808-26-000001 | Mar 13, 2026 | — |
| 144 | — | 0001294192-26-000001 | Mar 13, 2026 | — |
| 144 | — | 0001246842-26-000001 | Mar 13, 2026 | — |
| 144 | — | 0001969082-26-000003 | Mar 13, 2026 | — |
| 144 | — | 0001800668-26-000001 | Mar 13, 2026 | — |
| 4 | — | 0001610717-26-000087 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | — | 0001610717-26-000085 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000084 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000083 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000082 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000081 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000080 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | — | 0001610717-26-000079 | Mar 3, 2026 | Mar 1, 2026 |
| 144 | — | 0001950047-26-001991 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-001990 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-001988 | Mar 2, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-072036 | Feb 25, 2026 | — |
| S-8 | S-8 | 0001193125-26-071987 | Feb 25, 2026 | — |
| 10-K | 10-K | 0001193125-26-071563 | Feb 25, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-071517 | Feb 25, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016452 | Feb 17, 2026 | — |
| 4 | — | 0001610717-26-000048 | Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G/A | — | 0000902219-26-000036 | Feb 10, 2026 | — |
| SCHEDULE 13G/A | — | 0000908834-26-000064 | Feb 9, 2026 | — |
| 4 | — | 0001610717-26-000018 | Jan 23, 2026 | Jan 21, 2026 |
| 144 | — | 0001950047-26-000611 | Jan 21, 2026 | — |
| 4 | — | 0001610717-26-000013 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | — | 0001610717-26-000012 | Jan 9, 2026 | Jan 7, 2026 |
| 144 | — | 0001950047-26-000233 | Jan 7, 2026 | — |
| 144 | — | 0001950047-26-000232 | Jan 7, 2026 | — |
| 4 | — | 0001610717-25-000424 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | — | 0001610717-25-000423 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | — | 0001610717-25-000422 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | — | 0001610717-25-000421 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | — | 0001610717-25-000420 | Dec 18, 2025 | Dec 16, 2025 |